Immunomodulatory effects of cannabidiol and delta9-tetrahydrocannabinol in PBMCs and PBMC/rheumatoid synovial fibroblast co-cultures

descriptionPublicationkeyboard_double_arrow_right Conference object 14 Sep 2021 English Publisher:German Medical Science GMS Publishing House; Düsseldorf

Authors: Lowin, T; Kok, C; Pongratz, G;

doi: 10.3205/21dgrh045

Immunomodulatory effects of cannabidiol and delta9-tetrahydrocannabinol in PBMCs and PBMC/rheumatoid synovial fibroblast co-cultures

- Summary
- Subjects
- Metrics

Abstract

Introduction: In 2017, cannabis was legalized in Germany for medical use but studies supporting its use in rheumatic diseases are rare. The two main active ingredients of cannabis, delta tetrahydrocannabinol (THC) and cannabidiol (CBD) showed some effects in reducing pain in rheumatoid arthritis (RA)[for full text, please go to the a.m. URL]

Deutscher Rheumatologiekongress 2021, 49. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 35. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), Wissenschaftliche Herbsttagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)

Keywords

ddc: 610, 610 Medical sciences; Medicine

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average